View Cart (0 items)
Pharmaceutical

Chris Brinsmead named chairman of Proteus Biomedical Europe

September 15, 2011
/ Print / Reprints /
| Share More
/ Text Size+

REDWOOD CITY, Calif. — Proteus Biomedical Inc. announced today that Chris Brinsmead has joined the company as chairman of Proteus Biomedical Europe, according to a press release.

Brinsmead has more than 30 years of experience in the global pharmaceutical industry and most recently advised the United Kingdom government on health and life sciences policy.

He will be instrumental in guiding the commercial launch of Proteus''s first product, Helius™, and the development of Proteus’s organization in Europe.
You must login or register in order to post a comment.